NASDAQ · Packaged Foods · USD
BioHarvest Sciences Inc. Common Stock (BHST) Stock Analysis
BioHarvest Sciences Inc. Common Stock (BHST) is a Packaged Foods stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
BHST Key Statistics
As of Oct 21, 2026Trading
- Open
- $1.68
- Previous Close
- $1.68
- Day's Range
- 1.61–1.70
- 52-Week Range
- 1.37–12.20
- Volume
- 7.29K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.38
Valuation
- Market Cap
- $40.80M
- P/E Ratio
- unprofitable
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 1.15
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −0.51
Financials (FY)
- Revenue (FY)
- $34.51M+37.00%
- Net Income (FY)
- −$11.14M
- Profit marginThe share of revenue left as profit after all costs and taxes.
- −31.21%
- Shares Outstanding
- 22.67M
- 1-Year Return
- −84.87%
Dividend and dates
- Earnings Date
- November 12, 2026estimated
- Avg Volume
- 47.81K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, BHST closed at $1.67, −84.87% over 1 year.
BioHarvest Sciences Inc. Common Stock (BHST) has a market capitalization of $40.80M.
In fiscal 2025, BHST reported revenue of $34.51M.
BHST Stock Return by Calendar Year
BioHarvest Sciences Inc. Common Stock (BHST) return since Jan 2021: what $10,000 became
- 1 year
- $10,000 $1,513
- −84.87%
- 5 years
- $10,000 $1,670
- −83.30%
- Since Jan 2021
- $10,000 $1,647
- −83.53%
If you had invested $10,000 in BioHarvest Sciences Inc. Common Stock (BHST) at the close on January 8, 2021, the earliest close on record here, it would have been worth $1,647 at the close on October 21, 2026: −83.53% in total, −26.79% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −67.78% |
| 2025 | −16.02% |
| 2024 | +11.75% |
| 2023 | −27.52% |
| 2022 | −39.44% |
| 2021 | +24.14% |
As of October 21, 2026.
BHST Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $34.51M | −$11.14M | −32.3% |
| 2024 | $25.19M | −$12.91M | −51.3% |
| 2023 | $12.67M | −$12.56M | −99.1% |
| 2022 | $5.50M | −$11.24M | −204.4% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $34.51M | $20.48M | −$5.58M | −$11.14M | −32.3% |
| 2024 | $25.19M | $13.94M | −$6.99M | −$12.91M | −51.3% |
| 2023 | $12.67M | $5.63M | −$9.97M | −$12.56M | −99.1% |
| 2022 | $5.50M | $1.22M | −$10.61M | −$11.24M | −204.4% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
BHST Valuation vs Packaged Foods Median
Median of 70 stocks| Metric | BHST | Packaged Foods median | vs median |
|---|---|---|---|
| P/S ratio | 1.15 | 0.67 | 73% above |
| Profit margin | −31.21% | 2.27% | 33.5 pts below |
Medians across 70 Packaged Foods stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
BioHarvest takes second plant-cell asset to commercial readiness
Proactive InvestorsBioHarvest Advances Proprietary Olive Cell Asset to Commercial Readiness, Opening New CDMO Licensing Opportunity
YahooBioHarvest Sciences' Proprietary Olive Cell Composition Attains Commercial Readiness, Now Available For Licensing And Commercialization
BenzingaBioHarvest says its platform can produce target sweetener in Tate & Lyle program
Proactive InvestorsTate & Lyle and Bioharvest Reach Key Milestone in Next-Generation Sweetener Development Programme
YahooBioHarvest Sciences launches buyback of up to 5% of shares
Proactive Investors
All 19 articles ↓Show fewer ↑
BioHarvest Sciences Announces Share Repurchase Program
YahooBioHarvest Sciences Board Authorizes Normal Course Issuer Bid To Repurchase Up To 5% Of Outstanding Common Shares
BenzingaBioHarvest Sciences launches single-dose VINIA Daily Chews
Proactive InvestorsBioHarvest Advances Botanical Synthesis Leadership as VINIA Daily Chews Unlock More Value from Its First Consumer Product
YahooBioHarvest Sciences to Present at the H.C. Wainwright 28th Annual Global Investment Conference
YahooBioHarvest Sciences plans Tel Aviv Stock Exchange dual listing
Proactive InvestorsBioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
YahooMaxim Group Maintains Buy on BioHarvest Sciences, Lowers Price Target to $5
BenzingaRoth Capital Maintains Buy on BioHarvest Sciences, Lowers Price Target to $8
BenzingaConference Call: BioHarvest Sciences Lowers FY2026 Sales Guidance from $42.000M-$48.000M to $37.000M-$40.000M vs $42.914M Est
BenzingaBioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call Transcript
SeekingAlphaBioHarvest Sciences Revises FY26 CDMO Revenue Guidance to $4M-$5M from $4M-$6M; VINIA D2C Revenue Guidance to $33M-$35M from $38M-$42M
BenzingaBioHarvest Sciences Enters Agreement For A Rare, Endangered Fragrance Plant Cell Culture With A UAE-Based Customer; Sees $20M-$30M In 2027-28 Sales
Benzinga
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Packaged Foods Stocks
The Kraft Heinz Company
$27.87B
GISGeneral Mills, Inc.
$17.41B
SAP.TOSaputo Inc.
CA$16.14B
SJMThe J. M. Smucker Company
$13.65B
JBSJBS N.V.
$13.35B
MKCMcCormick & Company, Incorporated
$12.46B
Popular Consumer Defensive Stocks
Walmart Inc.
$937.46B
COSTCostco Wholesale Corporation
$442.38B
KOThe Coca-Cola Company
$398.76B
PGThe Procter & Gamble Company
$364.29B
PMPhilip Morris International Inc.
$307.76B












